These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28242867)

  • 1. Living Donor Liver Transplantation for Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Experience of a Single Center.
    Chang CC; Chen YJ; Huang TH; Chen CH; Kuo FY; Eng HL; Yong CC; Liu YW; Lin TL; Li WF; Lin YH; Lin CC; Wang CC; Chen CL
    Ann Transplant; 2017 Feb; 22():115-120. PubMed ID: 28242867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
    Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation in patients with hepatocellular carcinoma: a single-center experience.
    Azzam AZ; Hegab B; Khalaf H; Al Bahili H; Mohammed H; Kamel Y; Abaalkhail F; Al-hamoudi W; Al Sofayan M; Al Sebayel M
    Exp Clin Transplant; 2011 Oct; 9(5):323-8. PubMed ID: 21967259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
    Allam N; Khalaf H; Fagih M; Al-Sebayel M
    Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma.
    Park YH; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Namgoong JM; Park CS; Park HW; Kang SH; Jung BH; Lee SG
    Transplant Proc; 2013 Oct; 45(8):3038-40. PubMed ID: 24157031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.
    Vakili K; Pomposelli JJ; Cheah YL; Akoad M; Lewis WD; Khettry U; Gordon F; Khwaja K; Jenkins R; Pomfret EA
    Liver Transpl; 2009 Dec; 15(12):1861-6. PubMed ID: 19938113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW; Yi NJ; Suh KS
    Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation for hepatocellular carcinoma within the Milan criteria versus the University of California San Francisco criteria: a comparative study.
    Abdelfattah MR; Elsiesy H; Al-Manea H; Broering DC
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):398-403. PubMed ID: 29280920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation and combined hepatocellular-cholangiocarcinoma: Feasibility and outcomes.
    Magistri P; Tarantino G; Serra V; Guidetti C; Ballarin R; Di Benedetto F
    Dig Liver Dis; 2017 May; 49(5):467-470. PubMed ID: 28258929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma: outcome after liver transplantation.
    Maganty K; Levi D; Moon J; Bejarano PA; Arosemena L; Tzakis A; Martin P
    Dig Dis Sci; 2010 Dec; 55(12):3597-601. PubMed ID: 20848202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of living-donor liver transplantation for combined hepatocellular-cholangiocarcinoma.
    Itoh S; Ikegami T; Yoshizumi T; Wang H; Takeishi K; Harimoto N; Yamashita Y; Kawanaka H; Aishima S; Shirabe K; Maehara Y
    Anticancer Res; 2015 Apr; 35(4):2475-6. PubMed ID: 25862916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living donor liver transplantation for hepatocellular carcinoma in patients exceeding the UCSF criteria.
    Fouzas I; Sotiropoulos GC; Lang H; Nadalin S; Beckebaum S; Sgourakis G; Saner FH; Radtke A; Papanikolaou V; Baba HA; Paul A; Broelsch CE; Malagó M
    Transplant Proc; 2008 Nov; 40(9):3185-8. PubMed ID: 19010228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for "very early" intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment.
    Sapisochin G; Facciuto M; Rubbia-Brandt L; Marti J; Mehta N; Yao FY; Vibert E; Cherqui D; Grant DR; Hernandez-Alejandro R; Dale CH; Cucchetti A; Pinna A; Hwang S; Lee SG; Agopian VG; Busuttil RW; Rizvi S; Heimbach JK; Montenovo M; Reyes J; Cesaretti M; Soubrane O; Reichman T; Seal J; Kim PT; Klintmalm G; Sposito C; Mazzaferro V; Dutkowski P; Clavien PA; Toso C; Majno P; Kneteman N; Saunders C; Bruix J;
    Hepatology; 2016 Oct; 64(4):1178-88. PubMed ID: 27481548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery for Hepatocellular Carcinoma in Patients with Child-Pugh B Cirrhosis: Hepatic Resection Versus Living Donor Liver Transplantation.
    Harimoto N; Yoshizumi T; Fujimoto Y; Motomura T; Mano Y; Toshima T; Itoh S; Harada N; Ikegami T; Uchiyama H; Soejima Y; Maehara Y
    World J Surg; 2018 Aug; 42(8):2606-2616. PubMed ID: 29372372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic Cholangiocarcinoma in the Liver Explant After Liver Transplantation: Histological Differentiation and Prognosis.
    Takahashi K; Obeid J; Burmeister CS; Bruno DA; Kazimi MM; Yoshida A; Abouljoud MS; Schnickel GT
    Ann Transplant; 2016 Apr; 21():208-15. PubMed ID: 27068242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors of Tumor Recurrence After Liver Transplantation for Combined Hepatocellular Carcinoma and Cholangiocarcinoma.
    Park WK; Joshi PK; Lee KW; Lee KB; Hong SK; Yoon KC; Lee JM; Cho JH; Yi NJ; Suh KS
    Transplant Proc; 2020; 52(1):271-275. PubMed ID: 31926744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Diagnosis and Prognosis After Resection or Transplantation.
    Wu CH; Yong CC; Liew EH; Tsang LL; Lazo M; Hsu HW; Ou HY; Yu CY; Chen TY; Huang TL; Concejero AM; Chen CL; Cheng YF
    Transplant Proc; 2016 May; 48(4):1100-4. PubMed ID: 27320566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living-donor liver transplantation for hepatocellular carcinoma.
    Kawasaki S
    Hepatogastroenterology; 2002; 49(43):53-5. PubMed ID: 11941984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.